LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

Search

Mirati Therapeutics Inc

Open

SectorGezondheidszorg

0

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

Max

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

-0.05% downside

Nieuwssentiment

By Acuity

100%

0%

320 / 344 Rangschikking in Healthcare

Mirati Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

10 jun 2026, 23:53 UTC

News
Correlated Moves

Silver/GBP declines amid geopolitical tensions in Iran and rising U.S. inflation, breaking a recent trend of higher daily closes. Gold also trades lower.

10 jun 2026, 23:52 UTC

News
Correlated Moves

SPDR Gold Shares are trading lower after reports of explosions in Tehran raise regional stability concerns, prompting investors to seek safe-haven assets.

10 jun 2026, 23:52 UTC

News
Correlated Moves

Silver/JPY is trading lower as geopolitical tensions in Iran affect investor sentiment and contribute to fluctuations in precious metals. Gold's decline also impacts silver prices.

10 jun 2026, 23:52 UTC

News
Correlated Moves

Silver prices are lower amid geopolitical tensions in Iran and rising U.S. inflation, breaking a recent trend of higher daily closes.

10 jun 2026, 23:52 UTC

News
Correlated Moves

Silver/CAD declines amid geopolitical tensions in Iran and rising U.S. inflation, reversing a trend of higher daily closes. Gold also trades lower in correlation.

10 jun 2026, 23:52 UTC

News
Correlated Moves

Silver declines amid geopolitical tensions in Iran and rising U.S. inflation, breaking a recent trend of higher daily closes. Gold also shows a downward movement.

10 jun 2026, 23:51 UTC

News
ETF Constituents

The Vanguard Growth ETF is lower in after-market hours, impacted by declines in major holdings like Amazon and AMD amid broader geopolitical tensions.

10 jun 2026, 23:46 UTC

News

Starbucks Corp reported strong Q2 results and positive FY26 guidance. Shares are modestly higher in after-market trading, recovering from an earlier dip.

10 jun 2026, 23:44 UTC

News
Social Media
ETF Constituents
Correlated Moves

Invesco QQQ Trust trades lower in after-market hours amid rising geopolitical tensions and inflation concerns, reflecting declines in major holdings like AMD.

10 jun 2026, 23:42 UTC

News
Social Media

Tesla Inc shares are lower in after-market hours amid broader market declines. The company has started delivering its Cybertruck variant priced at $59,990.

10 jun 2026, 23:41 UTC

Macro News
News
ETF Constituents
Correlated Moves

Vanguard Information Technology ETF is lower in after-market hours amid declining tech stocks and rising geopolitical tensions between the U.S. and Iran.

10 jun 2026, 23:41 UTC

News
Correlated Moves
Social Media

AMD declines in after-market trading amid AI demand concerns.

10 jun 2026, 23:41 UTC

News
Social Media
Correlated Moves

Micron Technology Inc. shares are lower in after-market hours amid a broader market decline and ongoing pressures in the semiconductor sector.

10 jun 2026, 23:31 UTC

News
Correlated Moves

The iShares 20+ Year Treasury Bond ETF is lower in after-market hours, following CPI data that raised inflation concerns and speculation on Federal Reserve policies.

10 jun 2026, 23:31 UTC

News
Correlated Moves

Intel Corp shares are lower in after-market hours amid broader market declines and ongoing geopolitical tensions affecting investor sentiment in the semiconductor sector.

10 jun 2026, 23:31 UTC

News
ETF Constituents
Correlated Moves

The iShares Russell 2000 ETF is trading lower in after-market hours, following a decline in the Russell 2000 Index amid inflation concerns.

10 jun 2026, 23:22 UTC

News
Social Media
Correlated Moves
ETF Constituents

SPDR S&P 500 ETF Trust declines in after-market trading amid broader market weakness. Concerns rise as SPY breaks below $724 and geopolitical tensions persist.

10 jun 2026, 23:21 UTC

News

iShares Silver Trust declines in after-market hours amid geopolitical tensions and rising U.S. inflation, breaking a recent trend of higher daily closes.

10 jun 2026, 23:12 UTC

News
Social Media
Correlated Moves

Meta Platforms is lower in after-market hours amid a broader market decline. The company is building a data center in Gujarat, India.

10 jun 2026, 23:11 UTC

News

Silver is trading higher during Wednesday's session, influenced by geopolitical tensions in Iran that may affect regional stability and global supply chains.

10 jun 2026, 23:06 UTC

News
Correlated Moves
Macro Event

Ethereum is trading lower amid rising inflation concerns and geopolitical tensions. The asset's decline aligns with Bitcoin's recent drop in market sentiment.

10 jun 2026, 23:03 UTC

News
Correlated Moves
Social Media

Microsoft shares are lower in after-market hours amid reports of significant layoffs in its Xbox division as part of a restructuring effort.

10 jun 2026, 23:02 UTC

News

United States Oil Fund LP gains in after-market trading amid military strikes on Iran, reflecting heightened geopolitical tensions and their impact on crude oil sentiment.

10 jun 2026, 23:02 UTC

News
ETF Constituents
Social Media
Correlated Moves

U.S. stock indices fell in after-market hours, driven by rising energy costs and inflation concerns. The SPDR Dow Jones Industrial Average ETF Trust declined alongside key holdings.

10 jun 2026, 21:02 UTC

News

Incyte shares rise in after-market trading on Guggenheim target increase.

10 jun 2026, 20:07 UTC

News
Correlated Moves

USD/NOK declines as May budget deficit of -$293 billion exceeds expectations. The pair briefly rebounded earlier but has since fallen during the session.

10 jun 2026, 20:07 UTC

News
Correlated Moves

The U.S. federal budget deficit for May was -$293 billion, surpassing expectations. USD/PLN is trading higher, reflecting a cumulative increase since Tuesday.

10 jun 2026, 20:07 UTC

Correlated Moves
News
Macro Event

The U.S. federal budget deficit for May reached -$293 billion, exceeding forecasts. The USD/SEK exchange rate is advancing amid persistent inflationary pressures.

10 jun 2026, 20:07 UTC

News
Correlated Moves

U.S. federal budget deficit for May reached -$293 billion, larger than expected. USD/SGD trading roughly flat amid this macro backdrop.

10 jun 2026, 20:07 UTC

News
Macro Event
Correlated Moves

The U.S. budget deficit for May reached $293 billion, surpassing forecasts. The USD/CZK exchange rate is trading higher amid mortgage rate volatility.

Peer Vergelijking

Prijswijziging

Mirati Therapeutics Inc Prognose

Koersdoel

By TipRanks

-0.05% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 58.67 USD  -0.05%

Hoogste 59 USD

Laagste 58 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Mirati Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

5 ratings

0

Buy

5

Hold

0

Sell

Sentiment

By Acuity

320 / 344 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

EBITDA

Operationele winst

$

Over Mirati Therapeutics Inc

Mirati Therapeutics, Inc. is a clinical-stage oncology company. It is focused on developing therapeutics to address the genetic and immunological promoters of cancer. Its clinical programs consist of product candidates, including Adagrasib (MRTX849), MRTX1133, and Sitravatinib. MRTX849 is an oral small-molecule therapy designed to shrink difficult-to-treat cancers harboring the KRAS G12C mutation. MRTX1133 is a small molecule-inhibitor of the KRASG12D mutation, designed to treat patients with unmet need. Sitravatinib is a spectrum-selective receptor tyrosine kinase (RTK) inhibitor that can stimulate the body’s immune response to fight cancer. MRTX849 is in Phase III and Phase I/II clinical trials and MRTX1133 is in preclinical development. Sitravatinib is in a Phase III clinical trial, and Phase I/II clinical trials. It also has additional preclinical discovery programs, which includes first-in-class and best-in-class product candidates designed to address mutations and tumors.
help-icon Live chat